Chemoinformaics analysis of Podioda-7,17,21-triene
| Molecular Weight | 410.73 | nRot | 7 |
| Heavy Atom Molecular Weight | 360.33 | nRig | 17 |
| Exact Molecular Weight | 410.391 | nRing | 3 |
| Solubility: LogS | -7.457 | nHRing | 0 |
| Solubility: LogP | 9.235 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 83.4397 |
| nHD | 0 | BPOL | 50.1604 |
| QED | 0.289 |
| Synth | 4.623 |
| Natural Product Likeliness | 3.021 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.038 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.672 |
| MDCK | 0.0000059 |
| BBB | 0.087 |
| PPB | 0.983218 |
| VDSS | 4.987 |
| FU | 0.0227763 |
| CYP1A2-inh | 0.059 |
| CYP1A2-sub | 0.192 |
| CYP2c19-inh | 0.146 |
| CYP2c19-sub | 0.905 |
| CYP2c9-inh | 0.163 |
| CYP2c9-sub | 0.697 |
| CYP2d6-inh | 0.376 |
| CYP2d6-sub | 0.765 |
| CYP3a4-inh | 0.614 |
| CYP3a4-sub | 0.279 |
| CL | 6.317 |
| T12 | 0.009 |
| hERG | 0.032 |
| Ames | 0.001 |
| ROA | 0.027 |
| SkinSen | 0.933 |
| Carcinogencity | 0.04 |
| EI | 0.864 |
| Respiratory | 0.229 |
| NR-Aromatase | 0.237 |
| Antiviral | No |
| Prediction | 0.65342 |